Lai Quintin J
SEC CIK 1744326 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WST | West Pharmaceutical Services | VP Strat, Investor Relations | 4,359 | — | $15.77M | 9 | 2021-09-10 | 2024-02-20 |
Most active insiders at WST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Favorite Annette F | SVP, Chief HR Off | — | $6.30M |
| 2 | Winters Chad | VP, CAO | — | $269.4K |
| 3 | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | — | — |
| 4 | Campbell Shane Alden | SVP, Proprietary Segment | — | — |
| 5 | Lockhart Stephen H | Dir | — | — |
| 6 | Witherspoon Charles | VP, Treas | — | — |
| 7 | Joseph Molly | Dir | — | — |
| 8 | McMahon Robert W. | SVP, CFO | — | — |
| 9 | Feehery William F | Dir | — | — |
| 10 | Pucci Paolo | Dir | — | — |
Lai Quintin J made no open-market trades at WST in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | WST | West Pharmaceutical Services | Lai Quintin J | VP Strat, Investor Relations | A - Grant | $0.00 | +375 | 4,359 | +9% | $0 | |
| DM | 2023-08-15 | 2023-08-11 | WST | West Pharmaceutical Services | Lai Quintin J | VP Strat, Investor Relations | S - Sale+OE | $395.12 | -21.1K | 18.3K | -54% | -$8.34M |
| DM | 2023-08-15 | 2023-08-11 | WST | West Pharmaceutical Services | Lai Quintin J | VP Strat, Investor Relations | M - OptEx | $125.40 | +21.1K | 39.4K | +115% | +$2.65M |
| D | 2023-02-23 | 2023-02-21 | WST | West Pharmaceutical Services | Lai Quintin J | VP Corp Development, Strategy | A - Grant | $306.68 | +1,134 | 18.3K | +7% | +$347.8K |
| DM | 2022-03-16 | 2022-03-14 | WST | West Pharmaceutical Services | Lai Quintin J | VP Corp Development, Strategy | S - Sale+OE | $371.69 | -8,016 | 12.1K | -40% | -$2.98M |
| DM | 2022-03-16 | 2022-03-14 | WST | West Pharmaceutical Services | Lai Quintin J | VP Corp Development, Strategy | M - OptEx | $86.76 | +8,016 | 7,812 | New | +$695.4K |
| 2022-02-24 | 2022-02-22 | WST | West Pharmaceutical Services | Lai Quintin J | VP Corp Development, Strategy | A - Grant | $369.13 | +3,138 | 5,372 | +140% | +$1.16M | |
| DM | 2021-09-14 | 2021-09-10 | WST | West Pharmaceutical Services | Lai Quintin J | VP Corp Development, Strategy | M - OptEx | $61.02 | +9,672 | 11.9K | +433% | +$590.2K |
| DM | 2021-09-14 | 2021-09-10 | WST | West Pharmaceutical Services | Lai Quintin J | VP Corp Development, Strategy | S - Sale+OE | $460.76 | -9,672 | 2,234 | -81% | -$4.46M |
Purchase Sale Sale after option exercise All abbreviations